|
1
|
Long J, Luo GP, Xiao ZW, Liu ZQ, Guo M,
Liu L, Liu C, Xu J, Gao YT, Zheng Y, et al: Cancer statistics:
Current diagnosis and treatment of pancreatic cancer in Shanghai,
China. Cancer Lett. 346:273–277. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Koay EJ, Amer AM, Baio FE, Ondari AO and
Fleming JB: Toward stratification of patients with pancreatic
cancer: Past lessons from traditional approaches and future
applications with physical biomarkers. Cancer Lett. 381:237–243.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hackert T, Ulrich A and Büchler MW:
Borderline resectable pancreatic cancer. Cancer Lett. 375:231–237.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hartwig W, Werner J, Jäger D, Debus J and
Büchler MW: Improvement of surgical results for pancreatic cancer.
Lancet Oncol. 14:e476-e4852013. View Article : Google Scholar
|
|
6
|
Kamisawa T, Wood LD, Itoi T and Takaori K:
Pancreatic cancer. Lancet. 388:73–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu L, Xu H, Wang W, Wu C, Chen Y, Yang J,
Cen P, Xu J, Liu C, Long J, et al: A preoperative serum signature
of CEA+/CA125+/CA19-9 ≥ 1000 U/ml indicates poor outcome to
pancreatectomy for pancreatic cancer. Int J Cancer. 136:2216–2227.
2015. View Article : Google Scholar
|
|
8
|
Bhr C, Rohwer A, Stempka L, Rincke G,
Marks F and Gschwendt M: DIK, a novel protein kinase that interacts
with protein kinase Cdelta. Cloning, characterization, and gene
analysis. J Biol Chem. 275:36350–36357. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang D, Lin J and Han J:
Receptor-interacting protein (RIP) kinase family. Cell Mol Immunol.
7:243–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Azizmohammadi S, Azizmohammadi S, Safari
A, Kaghazian M, Sadrkhanlo M, Behnod V and Seifoleslami M:
High-level expression of RIPK4 and EZH2 contributes to lymph node
metastasis and predicts favorable prognosis in patients with
cervical cancer. Oncol Res. 25:495–501. 2017. View Article : Google Scholar
|
|
11
|
Liu DQ, Li FF, Zhang JB, Zhou TJ, Xue WQ,
Zheng XH, Chen YB, Liao XY, Zhang L, Zhang SD, et al: Increased
RIPK4 expression is associated with progression and poor prognosis
in cervical squamous cell carcinoma patients. Sci Rep. 5:119552015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang X, McGann JC, Liu BY, Hannoush RN,
Lill JR, Pham V, Newton K, Kakunda M, Liu J, Yu C, et al:
Phosphorylation of Dishevelled by protein kinase RIPK4 regulates
Wnt signaling. Science. 339:1441–1445. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee P, Jiang S, Li Y, Yue J, Gou X, Chen
SY, Zhao Y, Schober M, Tan M and Wu X: Phosphorylation of Pkp1 by
RIPK4 regulates epidermal differentiation and skin tumorigenesis.
EMBO J. 36:1963–1980. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang X, Zhu W, Zhou Y, Xu W and Wang H:
RIPK4 is down-regulated in poorly differentiated tongue cancer and
is associated with migration/invasion and cisplatin-induced
apoptosis. Int J Biol Markers. 29:e150-e1592014. View Article : Google Scholar
|
|
15
|
Yeung K, Janosch P, McFerran B, Rose DW,
Mischak H, Sedivy JM and Kolch W: Mechanism of suppression of the
Raf/MEK/extracellular signal-regulated kinase pathway by the raf
kinase inhibitor protein. Mol Cell Biol. 20:3079–3085. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yeung K, Seitz T, Li S, Janosch P,
McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, et
al: Suppression of Raf-1 kinase activity and MAP kinase signalling
by RKIP. Nature. 401:173–177. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song SP, Zhang SB, Li ZH, Zhou YS, Li B,
Bian ZW, Liao QD and Zhang YD: Reduced expression of Raf kinase
inhibitor protein correlates with poor prognosis in pancreatic
cancer. Clin Transl Oncol. 14:848–852. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Karamitopoulou E, Zlobec I, Gloor B,
Kondi-Pafiti A, Lugli A and Perren A: Loss of Raf-1 kinase
inhibitor protein (RKIP) is strongly associated with high-grade
tumor budding and correlates with an aggressive phenotype in
pancreatic ductal adenocarcinoma (PDAC). J Transl Med. 11:3112013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim HS, Kim GY, Lim SJ and Kim YW: Loss of
Raf-1 kinase inhibitory protein in pancreatic ductal
adenocarcinoma. Pathology. 42:655–660. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hellmann J, Rommelspacher H and Wernicke
C: Long-term ethanol exposure impairs neuronal differentiation of
human neuroblastoma cells involving neurotrophin-mediated
intracellular signaling and in particular protein kinase C. Alcohol
Clin Exp Res. 33:538–550. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moen EL, Wen S, Anwar T, Cross-Knorr S,
Brilliant K, Birnbaum F, Rahaman S, Sedivy JM, Moss SF and
Chatterjee D: Regulation of RKIP function by Helicobacter pylori in
gastric cancer. PLoS One. 7:e378192012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Furukawa T, Duguid WP, Rosenberg L,
Viallet J, Galloway DA and Tsao MS: Long-term culture and
immortalization of epithelial cells from normal adult human
pancreatic ducts trans-fected by the E6E7 gene of human papilloma
virus 16. Am J Pathol. 148:1763–1770. 1996.PubMed/NCBI
|
|
23
|
Qi Z, Liu M, Liu Y, Zhang M and Yang G:
Tetramethoxychalcone, a chalcone derivative, suppresses
proliferation, blocks cell cycle progression, and induces apoptosis
of human ovarian cancer cells. PLoS One. 9:e1062062014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Warde-Farley D, Donaldson SL, Comes O,
Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT,
et al: The GeneMANIA prediction server: Biological network
integration for gene prioritization and predicting gene function.
Nucleic Acids Res. 38(Suppl 2): W214–W220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maines MD: Biliverdin reductase: PKC
interaction at the crosstalk of MAPK and PI3K signaling pathways.
Antioxid Redox Signal. 9:2187–2195. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mugami S, Dobkin-Bekman M, Rahamim-Ben
Navi L and Naor Z: Differential roles of PKC isoforms (PKCs) in
GnRH stimulation of MAPK phosphorylation in gonadotrope derived
cells. Mol Cell Endocrinol. Apr 6–2017.Epub ahead of print.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dai H, Chen H, Liu W, You Y, Tan J, Yang
A, Lai X and Bie P: Effects of Raf kinase inhibitor protein
expression on pancreatic cancer cell growth and motility: An in
vivo and in vitro study. J Cancer Res Clin Oncol. 142:2107–2117.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Corbit KC, Trakul N, Eves EM, Diaz B,
Marshall M and Rosner MR: Activation of Raf-1 signaling by protein
kinase C through a mechanism involving Raf kinase inhibitory
protein. J Biol Chem. 278:13061–13068. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Baritaki S, Yeung K, Palladino M, Berenson
J and Bonavida B: Pivotal roles of snail inhibition and RKIP
induction by the proteasome inhibitor NPI-0052 in tumor cell
chemoimmunosensitization. Cancer Res. 69:8376–8385. 2009.
View Article : Google Scholar : PubMed/NCBI
|
